MX394479B - Composiciones para activación de nrf2 mejorada y sus métodos de uso. - Google Patents
Composiciones para activación de nrf2 mejorada y sus métodos de uso.Info
- Publication number
- MX394479B MX394479B MX2018002743A MX2018002743A MX394479B MX 394479 B MX394479 B MX 394479B MX 2018002743 A MX2018002743 A MX 2018002743A MX 2018002743 A MX2018002743 A MX 2018002743A MX 394479 B MX394479 B MX 394479B
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- methods
- enhanced
- nrf2 activation
- phytochemicals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562214175P | 2015-09-03 | 2015-09-03 | |
| US201662355810P | 2016-06-28 | 2016-06-28 | |
| PCT/US2016/050292 WO2017041054A1 (en) | 2015-09-03 | 2016-09-02 | Compositions for improved nrf2 activation and methods of their use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018002743A MX2018002743A (es) | 2018-06-06 |
| MX394479B true MX394479B (es) | 2025-03-24 |
Family
ID=58188643
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018002743A MX394479B (es) | 2015-09-03 | 2016-09-02 | Composiciones para activación de nrf2 mejorada y sus métodos de uso. |
| MX2022009446A MX2022009446A (es) | 2015-09-03 | 2018-03-02 | Composiciones para activacion de nrf2 mejorada y sus metodos de uso. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022009446A MX2022009446A (es) | 2015-09-03 | 2018-03-02 | Composiciones para activacion de nrf2 mejorada y sus metodos de uso. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11413269B2 (enExample) |
| JP (1) | JP6901787B2 (enExample) |
| CN (2) | CN108136209A (enExample) |
| CL (1) | CL2018000573A1 (enExample) |
| CO (1) | CO2018003454A2 (enExample) |
| HK (1) | HK1256480A1 (enExample) |
| MX (2) | MX394479B (enExample) |
| PE (1) | PE20190380A1 (enExample) |
| WO (1) | WO2017041054A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220354916A1 (en) * | 2015-09-03 | 2022-11-10 | Pathways Bioscience, Llc | Compositions for improved nrf2 activation and methods of their use |
| US10993981B2 (en) * | 2016-07-11 | 2021-05-04 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organiation (Aro), (Volcani Center) | Compositions for treatment of follicular tonsillitis using an emulsion based on rosemary extract and oregano essential oil |
| WO2018197394A1 (en) * | 2017-04-27 | 2018-11-01 | Dsm Ip Assets B.V. | Use of withania somnifera extract to protect against air pollution related diseases |
| WO2026163006A1 (en) * | 2025-01-28 | 2026-08-06 | Access Business Group International Llc | Compositions, methods comprising rosmarinus officinalis and zingiber officinale extracts for improving and/or extending healthspan |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5888514A (en) * | 1997-05-23 | 1999-03-30 | Weisman; Bernard | Natural composition for treating bone or joint inflammation |
| US9265808B2 (en) * | 2004-03-23 | 2016-02-23 | Lifeline Nutraceuticals Corporation | Compositions for alleviating inflammation and oxidative stress in a mammal |
| WO2006073042A1 (ja) * | 2005-01-05 | 2006-07-13 | Toagosei Co., Ltd. | Ｎｒｆ２依存遺伝子の活性化剤 |
| RU2008143294A (ru) * | 2006-04-03 | 2010-05-10 | Нестек С.А. (Ch) | Питательные композиции для стимуляции роста костей и поддержания здорового состояния костей и относящиеся к ним способы |
| US8142806B2 (en) | 2008-03-10 | 2012-03-27 | University Of Louisville Research Foundation, Inc. | Methods and compositions for controlled delivery of phytochemical agents |
| JP5608646B2 (ja) | 2008-07-31 | 2014-10-15 | シャクリー コーポレーション | 向上した抗酸化活性を有するマスカダイン組成物 |
| JP2011057654A (ja) | 2009-09-14 | 2011-03-24 | Iwate Univ | メタボリックシンドローム治療又は予防薬、及び脂肪細胞分化抑制方法 |
| WO2011075843A1 (en) | 2009-12-24 | 2011-06-30 | The Royal Institution For The Avancement Of Learning/Mcgill University | Compositions and methods for preventing and treating diseases and environmentally induced health disorders |
| KR101254847B1 (ko) * | 2010-05-27 | 2013-04-15 | 한림대학교 산학협력단 | 실리비닌(silibinin)을 포함하는 골다공증 치료 및 예방용 조성물 |
| WO2012142511A2 (en) | 2011-04-15 | 2012-10-18 | Md Matrix Health Llc Dba Md Matrix Health Inc | Orthomolecular compositions and their use in stabilizing the extracellular matrix |
| WO2013108056A1 (es) * | 2012-01-16 | 2013-07-25 | Velez-Rivera Hector De Jesus | Fitocomposición para el tratamiento de dolores relacionados con enfermedades articulares |
| JP2013209351A (ja) * | 2012-03-30 | 2013-10-10 | Sunstar Inc | 抗酸化機能亢進剤 |
| US20140287071A1 (en) * | 2013-01-17 | 2014-09-25 | Lifevantage Corporation | Veterinary supplements |
| WO2014151891A1 (en) * | 2013-03-14 | 2014-09-25 | Walley Darlene | Topical products |
| CA2917921C (en) * | 2013-07-17 | 2021-08-03 | Council Of Scientific & Industrial Research | Pharmaceutical composition for the treatment of diminution of bone tissue |
| WO2016037971A1 (en) * | 2014-09-08 | 2016-03-17 | Bios Line S.P.A. | Compositions comprising glucosinolates precursors of sulforaphane in combination with extracts of rosemary |
-
2016
- 2016-09-02 CN CN201680050947.0A patent/CN108136209A/zh active Pending
- 2016-09-02 MX MX2018002743A patent/MX394479B/es unknown
- 2016-09-02 JP JP2018531303A patent/JP6901787B2/ja active Active
- 2016-09-02 HK HK18115518.1A patent/HK1256480A1/zh unknown
- 2016-09-02 WO PCT/US2016/050292 patent/WO2017041054A1/en not_active Ceased
- 2016-09-02 CN CN202510745791.9A patent/CN120754114A/zh active Pending
- 2016-09-02 US US15/757,270 patent/US11413269B2/en active Active
- 2016-09-02 PE PE2018000340A patent/PE20190380A1/es unknown
-
2018
- 2018-03-02 CL CL2018000573A patent/CL2018000573A1/es unknown
- 2018-03-02 MX MX2022009446A patent/MX2022009446A/es unknown
- 2018-03-27 CO CONC2018/0003454A patent/CO2018003454A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO2018003454A2 (es) | 2018-08-31 |
| CL2018000573A1 (es) | 2019-01-11 |
| MX2022009446A (es) | 2022-09-05 |
| MX2018002743A (es) | 2018-06-06 |
| CN120754114A (zh) | 2025-10-10 |
| JP6901787B2 (ja) | 2021-07-14 |
| PE20190380A1 (es) | 2019-03-08 |
| HK1256480A1 (zh) | 2019-09-27 |
| JP2018529763A (ja) | 2018-10-11 |
| WO2017041054A1 (en) | 2017-03-09 |
| US11413269B2 (en) | 2022-08-16 |
| US20180250264A1 (en) | 2018-09-06 |
| CN108136209A (zh) | 2018-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123196T1 (el) | Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη | |
| CL2019000230A1 (es) | Composiciones y métodos de inhibición del masp-3 para el tratamiento de diversas enfermedades y trastornos. | |
| SA519401246B1 (ar) | (r) صياغات من-2- أمينو-3- فينيل بروبيل كربامات | |
| MX2018006240A (es) | Composiciones que comprenden cepas bacterianas. | |
| UY37134A (es) | Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4 | |
| EP3735976A3 (en) | Therapeutic use of mitochondria and combined mitochondrial agents | |
| SI3600270T1 (sl) | Spojine in sestavki za zdravljenje hematoloških motenj | |
| MX2018005315A (es) | Composiciones y metodos para el tratamiento del cancer. | |
| UY37036A (es) | Compuestos inhibidores de la quinasa de unión a tank | |
| MX378686B (es) | Composiciones que comprenden cepas bacterianas. | |
| MX2022007436A (es) | Inhibidores de la autotaxina y sus usos. | |
| MX2017012380A (es) | Derivados de maitansinoide, conjugados de los mismos, y metodos de uso. | |
| EP3380062A4 (en) | Compositions for treating the hair | |
| MX395231B (es) | Compuestos eficaces en el tratamiento de la hepatotoxicidad y enfermedades de hígado graso, y uso de los mismos. | |
| CL2016003074A1 (es) | Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer. | |
| PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| CL2023000892A1 (es) | Composiciones terapéuticas y métodos para el tratamiento de la hepatitis b (divisional). | |
| MX2017013729A (es) | Deteccion especifica de isoformas de clusterina. | |
| MX2017014456A (es) | Usos terapeuticos de l-4-cloroquinurenina. | |
| BR112017011685A2 (pt) | composições compreendendo 15-hepe e métodos de tratamento ou prevenção da fibrose usando as mesmas | |
| MX2022009446A (es) | Composiciones para activacion de nrf2 mejorada y sus metodos de uso. | |
| PL3373922T3 (pl) | Kompozycje i sposoby do stosowania do leczenia homocystynurii | |
| MX383386B (es) | Nuevos inhibidores de braf y uso de los mismos para el tratamiento de reacciones cutáneas. | |
| MX2018007128A (es) | Composiciones para barnices dentales y metodos para su elaboracion y uso. | |
| BR112017019154A2 (pt) | uso de frações isoladas de goma mástica para o tratamento de neuropatia óptica |